Therasense Stock Net Income
| THER Stock | USD 0.0001 0.00 0.00% |
In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Therasense, as well as the relationship between them.
Therasense's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Therasense's valuation are provided below:Therasense does not presently have any fundamental trend indicators for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Therasense |
Therasense 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Therasense's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Therasense.
| 11/12/2025 |
| 02/10/2026 |
If you would invest 0.00 in Therasense on November 12, 2025 and sell it all today you would earn a total of 0.00 from holding Therasense or generate 0.0% return on investment in Therasense over 90 days. Therasense is related to or competes with Rocket Pharmaceuticals, Aura Biosciences, Annexon, Solid Biosciences, Larimar Therapeutics, Altimmune, and Autolus Therapeutics. Theralink Technologies, Inc., a commercial-stage precision medicine and molecular data-generating company, engages in th... More
Therasense Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Therasense's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Therasense upside and downside potential and time the market with a certain degree of confidence.
Therasense Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Therasense's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Therasense's standard deviation. In reality, there are many statistical measures that can use Therasense historical prices to predict the future Therasense's volatility.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Therasense's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Therasense Backtested Returns
We have found three technical indicators for Therasense, which you can use to evaluate the volatility of the company. The entity has a beta of 0.0, which indicates not very significant fluctuations relative to the market. the returns on MARKET and Therasense are completely uncorrelated.
Auto-correlation | 1.00 |
Perfect predictability
Therasense has perfect predictability. Overlapping area represents the amount of predictability between Therasense time series from 12th of November 2025 to 27th of December 2025 and 27th of December 2025 to 10th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Therasense price movement. The serial correlation of 1.0 indicates that 100.0% of current Therasense price fluctuation can be explain by its past prices.
| Correlation Coefficient | 1.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Therasense reported net income of (7.75 Million). This is 102.27% lower than that of the Healthcare sector and 111.06% lower than that of the Biotechnology industry. The net income for all United States stocks is 101.36% higher than that of the company.
Therasense Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Therasense's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Therasense could also be used in its relative valuation, which is a method of valuing Therasense by comparing valuation metrics of similar companies.Therasense is currently under evaluation in net income category among its peers.
Therasense Fundamentals
| Return On Asset | -169.9 | |||
| Current Valuation | 27.3 M | |||
| Shares Outstanding | 6.15 B | |||
| Shares Owned By Insiders | 83.61 % | |||
| Number Of Shares Shorted | 199.92 K | |||
| Price To Book | 0.86 X | |||
| Price To Sales | 57.46 X | |||
| Revenue | 353.26 K | |||
| Gross Profit | 256.68 K | |||
| EBITDA | (5.53 M) | |||
| Net Income | (7.75 M) | |||
| Cash And Equivalents | 127.82 K | |||
| Total Debt | 2.9 M | |||
| Current Ratio | 0.22 X | |||
| Cash Flow From Operations | (5.54 M) | |||
| Short Ratio | 2.60 X | |||
| Earnings Per Share | (0) X | |||
| Number Of Employees | 16 | |||
| Beta | 22.12 | |||
| Market Capitalization | 20.3 M | |||
| Total Asset | 52 M | |||
| Retained Earnings | (248.68 M) | |||
| Working Capital | 6.84 M | |||
| Current Asset | 18.12 M | |||
| Current Liabilities | 11.29 M | |||
| Z Score | -1.4 |
About Therasense Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Therasense's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Therasense using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Therasense based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Therasense
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Therasense position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Therasense will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Therasense could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Therasense when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Therasense - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Therasense to buy it.
The correlation of Therasense is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Therasense moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Therasense moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Therasense can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Therasense Pink Sheet Analysis
When running Therasense's price analysis, check to measure Therasense's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Therasense is operating at the current time. Most of Therasense's value examination focuses on studying past and present price action to predict the probability of Therasense's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Therasense's price. Additionally, you may evaluate how the addition of Therasense to your portfolios can decrease your overall portfolio volatility.